Stratagene Posts $21M Bond to Secure Third Wave Damages; Files Notice of Appeal | GenomeWeb

Stratagene said last week that it had posted a $21-million bond to secure damages awarded to Third Wave as part of its patent-infringement suit against Stratagene, and has filed a notice of appeal in the case.

The bond, which was posted with the US District Court for the Western District of Wisconsin, is the latest development in a patent dispute between the firms that could drag on for another couple of years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.